Ann Surg 2009, 250:301–304 PubMedCrossRef 30 Bogenriender T,

Ann Surg 2009, 250:301–304.PubMedCrossRef 30. Bogenriender T,

Apoptosis inhibitor van Dijk MR, Bloky WA, TEW-7197 manufacturer Ramrath K, Seldenrijk K, Stolz W, van Diest PJ: No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumor load. Histopathol 2011, 59:318–326. 31. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK: Final version of, 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199–6206.PubMedCrossRef 32. Murali R, Cochran AJ, Cook MG, Hillman JD, Karim RZ, Moncrieff M, Starz H, Thompson JF, Scolyer RA: Inter-observer reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer 2009, 115:5026–5037.PubMedCrossRef 33. Veenstra HJ, Brouwer OR, van der Ploeg IM, Kroon BB, Nieweg OE: Five-year follow-up of 16 melanoma patients with a Starz I-involved sentinel node in whom completion lymph node dissection was omitted. Melanoma Res 2012,22(6):436–439.PubMedCrossRef PHA-848125 molecular weight 34. Maio M, Ascierto P, Testori A, Ridolfi R, Bajetta E, Queirolo

P, Guida M, Romanini A, Chiarion-Sileni V, Pigozzo J, Di Giacomo AM, Calandriello M, Didoni G, van Baardewijk M, Konto C, Lucioni C: The cost of unresectable stage III or stage IV melanoma in Italy. J Exp Clin Cancer Res 2012, 31:91.PubMedCrossRef 35. Solivetti MF, Elia F, Graceffa D, Di Carlo A: Ultrasound morphology of inguinal lymph nodes may not herald an associated pathology. J Exp Clin Cancer Res 2012, 31:88.PubMedCrossRef 36. Fabi A, Felici A, Metro G, Mirri A, Bria E, Telera S, Moscetti L, Russillo M, Lanzetta G, Mansueto G, Pace

A, Maschio M, Vidiri A, Sperduti I, Cognetti F, Carapella CM: Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center. J Exp Clin Cancer Res 2011, 30:10.PubMedCrossRef 37. von Akooi AC, Verhoef C, Eggermont AM: Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol 2010,7(8):446–454.CrossRef 38. Nagaraja V, Eslick GD: Is complete lymph node dissection after a positive Rapamycin mw sentinel lymoh node biopsy for cutaneous melanoma always necessary? A meta-analysis. Eur J Surg Oncol 2013,39(7):669–680.PubMedCrossRef Competing interest The authors declare that they have no competing interest. Authors’ contributions EM was the research leader, conceived the study, collected the clinical informations, drafted and revised the manuscript. BB and GP participated in clinical data collection-analysis and in manuscript drafting. FAG performed the critical revision of the research data and participated in the writing of the final manuscript. CC and SB contributed to the financial support of the research and were involved in the final approval of the manuscript.

Comments are closed.